(Q39169780)

English

Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients

scientific article published on 9 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

head and neck squamous cell carcinoma

0 references

adaptive radiation therapy

0 references

author name string

Lovisa Farnebo

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Katharina Tiefenböck

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Anna Ansell

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Lena K Thunell

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Stina Garvin

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Karin Roberg

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

language of work or name

0 references

publication date

9 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

133

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1994-2003

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Combining factors on protein and gene level to predict radioresponse in head and neck cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Studies on the inhibition of feline EGFR in squamous cell carcinoma: enhancement of radiosensitivity and rescue of resistance to small molecule inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Survivin expression in oral squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

High expression of survivin predicts poor prognosis in esophageal squamous cell carcinoma following radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Survivin expression and targeting in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

The impact of pharmacogenetics on radiation therapy outcome in cancer patients. A focus on DNA damage response genes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Modulation of DNA damage/DNA repair capacity by XPC polymorphisms

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Radiosensitivity of human fibroblasts is associated with amino acid substitution variants in susceptible genes and correlates with the number of risk alleles.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Changing patterns of tonsillar squamous cell carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

HPV infections and tonsillar carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Presence and influence of human papillomaviruses (HPV) in Tonsillar cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Prognostic importance of survivin in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Cellular localisation of Survivin: impact on the prognosis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Survivin expression in human osteosarcoma is a marker for survival

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Downregulation of survivin by RNAi inhibits the growth of esophageal carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Survivin as prognostic factor in squamous cell carcinoma of the oral cavity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28200

21 January 2018

Identifiers

10.1002/IJC.28200

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39169780&oldid=1811606390"